As US di­als up coro­n­avirus re­sponse, BIO taps Vir's George Scan­gos to head com­mit­tee co­or­di­nat­ing in­dus­try ef­forts

With two coro­n­avirus deaths record­ed on US turf, or­ga­ni­za­tions around the coun­try are di­al­ing their re­sponse to a pos­si­ble epi­dem­ic.

BIO, the biotech trade group, has ap­point­ed­ed its own coro­n­avirus czar — George Scan­gos of Vir Biotech­nol­o­gy — to co­or­di­nate the in­dus­try’s re­sponse, Reuters re­port­ed late Fri­day. Scan­gos, best known for his stint as Bio­gen CEO, and his in­fec­tious dis­ease start­up were one of the first to jump in­to the hunt for a treat­ment against Covid-19.

Scan­gos will lead an ad hoc com­mit­tee aimed at fa­cil­i­tat­ing ther­a­peu­tic, vac­cine and di­ag­nos­tics de­vel­op­ment and, to the ex­tent pos­si­ble, avoid du­pli­ca­tion of ef­forts, BIO spokesper­son Rich Mas­ters told End­points News. Pre­cise func­tions are still be­ing ex­plored and will like­ly change over time.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER